Palbociclib in metastatic breast cancer: current evidence and real-life data

• Main Authors: Francesco Serra (Author), Pietro Lapidari (Author), Erica Quaquarini (Author), Barbara Tagliaferri (Author), Federico Sottotetti (Author), Raffaella Palumbo (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The purpose of this review is to summarize the background and latest evidence for the use of palbociclib, an oral, first-in-class, highly selective cyclin-dependent kinase 4/6 inhibitor, in advanced breast cancer, with a focus on some of the unanswered questions about the performance of this agent i...